Pear Therapeutics, Inc.: cost_of_revenue
| Value | {"amount": 5233000, "concept": "us-gaap:CostOfRevenue", "currency": "USD"} |
|---|---|
| Period | 2021-01-01 – 2021-12-31 |
| Status | current |
| Entity | Pear Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:29:14.646643+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/ae16e5dc-9c75-4b53-9c82-70cbeb94d043
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001835567-22-000010 · Open the official SEC filing →Retrieved: 2026-08-19T18:29:14.646643+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001835567/cost-of-revenue/2021-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/ae16e5dc-9c75-4b53-9c82-70cbeb94d043
History
- no predecessors — first report